Drawing for HYLOFLEX

USPTO serial 88481271

HYLOFLEX

Reviewed by CopyMark Law Group

Reg. 6342326Status 700Renewal
Filing date
Status date
Registration date
May 4, 2021
Examiner
VAGHANI, MAYUR C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HYLOFLEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rhett V. Barney

Rhett V. Barney Lee & Hayes, PC601 W. Riverside Ave. Suite 1400Spokane, WA 99201UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Animal feed supplements for medical purposes for cattle, pigs, sheep, goats and horses; animal feed additives for medical purposes for use as nutritional supplements for easing joint pain for cattle, pigs, sheep, goats and horses; anti-inflammatories, namely, pharmaceutical preparations and substances with anti-inflammatory properties for cattle, pigs, sheep, goats and horses; dietary supplements for cattle, pigs, sheep, goats and horses; dietetic beverages adapted for veterinary use for cattle, pigs, sheep, goats and horses; feed supplements for livestock, namely, for cattle, pigs, sheep, goats and horses; hyaluronic acid for pharmaceutical purposes for cattle, pigs, sheep, goats and horses; medicated supplements for foodstuffs for cattle, pigs, sheep, goats and horses; veterinary preparations for joint pain relief for cattle, pigs, sheep, goats and horses; veterinary preparations, namely, pain relief medication for cattle, pigs, sheep, goats and horses; veterinary pharmaceutical preparations for the treatment of joint pain for cattle, pigs, sheep, goats and horses; vitamin C preparations for cattle, pigs, sheep, goats and horses; vitamin supplements for animals; vitamin and mineral preparations for medical use for cattle, pigs, sheep, goats and horses; vitamin and mineral supplements for cattle, pigs, sheep, goats and horses; vitamin and mineral supplements for mixing with animal feed for cattle, pigs, sheep, goats and horses; vitamins and dietary food supplements for cattle, pigs, sheep, goats and horses; animal feed additive for use as a nutritional supplement for medical purposes for cattle, pigs, sheep, goats and horses; liquid vitamin supplements for cattle, pigs, sheep, goats and horses; pharmaceutical preparations for the treatment of musculo-skeletal disorders for cattle, pigs, sheep goats and horsesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 4, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 4, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 30, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 28, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 9, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 9, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 19, 2021IUAFUSE AMENDMENT FILED—
Feb 19, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 9, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 9, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 9, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 9, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 9, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 9, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 23, 2020TMBNTTAB RELEASE CASE TO TRADEMARKS—
Dec 23, 2020OP.TOPPOSITION TERMINATED NO. 999999—
Dec 23, 2020OP.DOPPOSITION DISMISSED NO. 999999—
Feb 19, 2020OP.IOPPOSITION INSTITUTED NO. 999999—
Nov 8, 2019ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 15, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 15, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 25, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 11, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 11, 2019DOCKASSIGNED TO EXAMINER—
Jun 30, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 24, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance